180 related articles for article (PubMed ID: 19904799)
1. Evaluation of novel epothilone analogues by means of a common pharmacophore and a QSAR pseudoreceptor model for taxanes and epothilones.
Forli S; Manetti F; Altmann KH; Botta M
ChemMedChem; 2010 Jan; 5(1):35-40. PubMed ID: 19904799
[No Abstract] [Full Text] [Related]
2. 3D QSAR studies of the interaction between beta-tubulin and microtubule stabilizing antimitotic agents (MSAA). A combined pharmacophore generation and pseudoreceptor modeling approach applied to taxanes and epothilones.
Manetti F; Forli S; Maccari L; Corelli F; Botta M
Farmaco; 2003 May; 58(5):357-61. PubMed ID: 12729829
[TBL] [Abstract][Full Text] [Related]
3. 3D QSAR models of interactions between beta-tubulin and microtubule stabilizing antimitotic agents (MSAA): a survey on taxanes and epothilones.
Manetti F; Maccari L; Corelli F; Botta M
Curr Top Med Chem; 2004; 4(2):203-17. PubMed ID: 14754454
[TBL] [Abstract][Full Text] [Related]
4. Preclinical discovery of ixabepilone, a highly active antineoplastic agent.
Lee FY; Borzilleri R; Fairchild CR; Kamath A; Smykla R; Kramer R; Vite G
Cancer Chemother Pharmacol; 2008 Dec; 63(1):157-66. PubMed ID: 18347795
[TBL] [Abstract][Full Text] [Related]
5. A common pharmacophore for epothilone and taxanes: molecular basis for drug resistance conferred by tubulin mutations in human cancer cells.
Giannakakou P; Gussio R; Nogales E; Downing KH; Zaharevitz D; Bollbuck B; Poy G; Sackett D; Nicolaou KC; Fojo T
Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2904-9. PubMed ID: 10688884
[TBL] [Abstract][Full Text] [Related]
6. The binding mode of epothilone A on alpha,beta-tubulin by electron crystallography.
Nettles JH; Li H; Cornett B; Krahn JM; Snyder JP; Downing KH
Science; 2004 Aug; 305(5685):866-9. PubMed ID: 15297674
[TBL] [Abstract][Full Text] [Related]
7. Epothilone analogues with benzimidazole and quinoline side chains: chemical synthesis, antiproliferative activity, and interactions with tubulin.
Dietrich SA; Lindauer R; Stierlin C; Gertsch J; Matesanz R; Notararigo S; Díaz JF; Altmann KH
Chemistry; 2009 Oct; 15(39):10144-57. PubMed ID: 19697384
[TBL] [Abstract][Full Text] [Related]
8. Overcoming tumor drug resistance with C2-modified 10-deacetyl-7-propionyl cephalomannines: a QSAR study.
Hansch C; Verma RP
Mol Pharm; 2009; 6(3):849-60. PubMed ID: 19334723
[TBL] [Abstract][Full Text] [Related]
9. Much anticipated--the bioactive conformation of epothilone and its binding to tubulin.
Heinz DW; Schubert WD; Höfle G
Angew Chem Int Ed Engl; 2005 Feb; 44(9):1298-301. PubMed ID: 15714588
[No Abstract] [Full Text] [Related]
10. 3D QSAR studies for the beta-tubulin binding site of microtubule-stabilizing anticancer agents (MSAAs): a pseudoreceptor model for taxanes based on the experimental structure of tubulin.
Maccari L; Manetti F; Corelli F; Botta M
Farmaco; 2003 Sep; 58(9):659-68. PubMed ID: 13679158
[TBL] [Abstract][Full Text] [Related]
11. The high-resolution solution structure of epothilone A bound to tubulin: an understanding of the structure-activity relationships for a powerful class of antitumor agents.
Carlomagno T; Blommers MJ; Meiler J; Jahnke W; Schupp T; Petersen F; Schinzer D; Altmann KH; Griesinger C
Angew Chem Int Ed Engl; 2003 Jun; 42(22):2511-5. PubMed ID: 12800173
[No Abstract] [Full Text] [Related]
12. Synthesis and SAR of C12-C13-oxazoline derivatives of epothilone A.
Pfeiffer B; Hauenstein K; Merz P; Gertsch J; Altmann KH
Bioorg Med Chem Lett; 2009 Jul; 19(14):3760-3. PubMed ID: 19433359
[TBL] [Abstract][Full Text] [Related]
13. QSAR modeling of taxane analogues against colon cancer.
Verma RP; Hansch C
Eur J Med Chem; 2010 Apr; 45(4):1470-7. PubMed ID: 20116905
[TBL] [Abstract][Full Text] [Related]
14. The tubulin-bound conformation of discodermolide derived by NMR studies in solution supports a common pharmacophore model for epothilone and discodermolide.
Sánchez-Pedregal VM; Kubicek K; Meiler J; Lyothier I; Paterson I; Carlomagno T
Angew Chem Int Ed Engl; 2006 Nov; 45(44):7388-94. PubMed ID: 17036370
[No Abstract] [Full Text] [Related]
15. Molecular mechanism of action of microtubule-stabilizing anticancer agents.
Prota AE; Bargsten K; Zurwerra D; Field JJ; Díaz JF; Altmann KH; Steinmetz MO
Science; 2013 Feb; 339(6119):587-90. PubMed ID: 23287720
[TBL] [Abstract][Full Text] [Related]
16. The binding mode of side chain- and C3-modified epothilones to tubulin.
Erdélyi M; Navarro-Vázquez A; Pfeiffer B; Kuzniewski CN; Felser A; Widmer T; Gertsch J; Pera B; Díaz JF; Altmann KH; Carlomagno T
ChemMedChem; 2010 Jun; 5(6):911-20. PubMed ID: 20432490
[TBL] [Abstract][Full Text] [Related]
17. Design, total synthesis, and evaluation of novel open-chain epothilone analogues.
Alhamadsheh MM; Hudson RA; Viranga Tillekeratne LM
Org Lett; 2006 Feb; 8(4):685-8. PubMed ID: 16468742
[TBL] [Abstract][Full Text] [Related]
18. Cyclostreptin (FR182877), an antitumor tubulin-polymerizing agent deficient in enhancing tubulin assembly despite its high affinity for the taxoid site.
Edler MC; Buey RM; Gussio R; Marcus AI; Vanderwal CD; Sorensen EJ; Díaz JF; Giannakakou P; Hamel E
Biochemistry; 2005 Aug; 44(34):11525-38. PubMed ID: 16114889
[TBL] [Abstract][Full Text] [Related]
19. Five new epothilone metabolites from Sorangium cellulosum strain So0157-2.
Wang J; Zhang H; Ying L; Wang C; Jiang N; Zhou Y; Wang H; Bai H
J Antibiot (Tokyo); 2009 Sep; 62(9):483-7. PubMed ID: 19575038
[TBL] [Abstract][Full Text] [Related]
20. Epothilone B and its analogs - a new family of anticancer agents.
Altmann KH
Mini Rev Med Chem; 2003 Mar; 3(2):149-58. PubMed ID: 12570848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]